Ipsat Therapies Ltd

Ipsat Therapies Ltd is a private Finnish biotechnology company developing its proprietary IPSAT™ ("Intestinal Protection System in Antibiotic Treatment") family of products in the anti-infective field.
Ipsat's focus is primarily on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections.
 

Press Release, Start of Phase IIB, 3rd December 2006

ARTICLE - Orally Administered Recombinant Metallo-b-Lactamase Preserves Colonization Resistance of Piperacillin-Tazobactam-Treated Mice

See how it works (Open animation)

Preventing Antibiotic Resistance and Prolonging the
Life-span of Antibiotics